🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The purpose of the study is to evaluate the immunogenicity and reactogenici...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-03-01
Trial ID
NCT01086423
Treatments Being Tested
This study is a Phase IV, open, randomized, multi-center, controlled vaccin...
Status
Completed
Location
Centro de Estudios en Infectologia Pediatrica - CEIP
Start Date
2013-05
Trial ID
NCT01831050
The purpose of this booster study is to evaluate the immune persistence in ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-01
Trial ID
NCT01449812
Treatments Being Tested
The study will evaluate the safety and reactogenicity of PoliorixTM given a...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-01
Trial ID
NCT00920439
Treatments Being Tested
Following licensing of PoliorixTM in Korea, this study will collect safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07
Trial ID
NCT00514033
Treatments Being Tested
The purpose of this study is to assess reactogenicity and safety of simulta...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12-03
Trial ID
NCT01094171
Treatments Being Tested
The purpose of the study is to assess the immunogenicity and safety of thre...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-13
Trial ID
NCT01106092
Treatments Being Tested
The study will evaluate the safety and reactogenicity of Poliorix given as ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-04
Trial ID
NCT00937404
Treatments Being Tested